Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Nearly twice as many patients on Zepbound lost at least 25% of their body weight as those on Wegovy. Additionally, 81.6% of Zepbound patients lost 10% or more, versus 60.5% of those on Wegovy.

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

Tailored Weight Loss for Men With Zepbound Zepbound is an advanced injectable ... Patients receive a full medical assessment, including a detailed review of health history and lifestyle factors.

Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from ...

Tailored Weight Loss for Men With Zepbound Zepbound is an advanced injectable medication ... Patients receive a full medical assessment, including a detailed review of health history and lifestyle ...

Participants achieved an average weight loss of 20.2% with Zepbound vs ... and for 4 weeks after each increase in your dose of Zepbound. Review these questions with your healthcare provider ...

2 In key secondary endpoints, Zepbound was superior across all weight reduction targets with 64.6% of participants treated with Zepbound achieving at least 15.0% weight loss compared to 40.1% on ...

Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 ...